Viking Therapeutics Stock Options

VKTX Stock  USD 28.95  0.60  2.12%   
Viking Therapeutics' latest option contracts expiring on May 16th 2025 are carrying combined implied volatility of 1.28 with a put-to-call open interest ratio of 0.38 over 71 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on May 16th 2025. The total put volume is at 402, with calls trading at the volume of 509. This yields a 0.79 put-to-call volume ratio.

Open Interest Against May 16th 2025 Option Contracts

Viking Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Viking Therapeutics' lending market. For example, when Viking Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Viking Therapeutics, he or she must hedge the risk by shorting Viking Therapeutics stock over its option's life.
The chart above shows Viking Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Viking Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Viking Therapeutics' option, there is no secondary market available for investors to trade.

Viking Therapeutics Maximum Pain Price Across 2025-05-16 Option Contracts

Max pain occurs when Viking Therapeutics' market makers reach a net positive position across all Viking Therapeutics' options at a strike price where option holders stand to lose the most money. By contrast, Viking Therapeutics' option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Viking Therapeutics

Analyzing Viking Therapeutics' in-the-money options over time can help investors to take a profitable long position in Viking Therapeutics regardless of its overall volatility. This is especially true when Viking Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Viking Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Viking Therapeutics' stock while costing only a fraction of its price.

Viking Therapeutics In The Money Call Balance

When Viking Therapeutics' strike price is surpassing the current stock price, the option contract against Viking Therapeutics stock is said to be in the money. When it comes to buying Viking Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Viking Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Viking Current Options Market Mood

Viking Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Viking Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Viking Therapeutics' options investors are not very successful. Viking Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Viking contract

Base on the Rule 16, the options market is currently suggesting that Viking Therapeutics will have an average daily up or down price movement of about 0.08% per day over the life of the 2025-05-16 option contract. With Viking Therapeutics trading at USD 28.95, that is roughly USD 0.0232. If you think that the market is fully incorporating Viking Therapeutics' daily price movement you should consider buying Viking Therapeutics options at the current volatility level of 1.28%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Viking Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Viking calls. Remember, the seller must deliver Viking Therapeutics stock to the call owner when a call is exercised.

Viking Therapeutics Option Chain

When Viking Therapeutics' strike price is surpassing the current stock price, the option contract against Viking Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Viking Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Viking. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Viking. It also shows strike prices and maturity days for a Viking Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
VKTX250516C00120000742120.00.01 - 0.150.16Out
Call
VKTX250516C0011500066115.00.0 - 2.161.14Out
Call
VKTX250516C0011000055110.00.0 - 0.220.09Out
Call
VKTX250516C00105000179105.00.0 - 2.171.19Out
Call
VKTX250516C001000001538100.00.0 - 0.250.12Out
Call
VKTX250516C0009500044595.00.0 - 0.30.18Out
Call
VKTX250516C00090000143290.00.0 - 1.090.25Out
Call
VKTX250516C0008500026685.00.01 - 2.240.75Out
Call
VKTX250516C0008250018082.50.0 - 2.250.2Out
Call
VKTX250516C00080000151780.00.1 - 0.20.19Out
Call
VKTX250516C000775003477.50.0 - 2.280.31Out
Call
VKTX250516C00075000106075.00.0 - 0.380.26Out
Call
VKTX250516C0007250029372.50.0 - 2.320.4Out
Call
VKTX250516C00070000218270.00.2 - 1.510.25Out
Call
VKTX250516C0006750012967.50.0 - 1.01.0Out
Call
VKTX250516C00065000121465.00.02 - 0.430.26Out
Call
VKTX250516C0006250028362.50.19 - 0.60.31Out
Call
VKTX250516C00060000192060.00.32 - 0.630.38Out
Call
VKTX250516C0005750040857.50.31 - 1.130.49Out
Call
VKTX250516C0005500069155.00.37 - 2.180.54Out
Call
VKTX250516C0005250038952.50.0 - 0.980.66Out
Call
VKTX250516C00050000771650.00.58 - 0.70.58Out
Call
VKTX250516C0004750020347.50.52 - 1.110.74Out
Call
VKTX250516C00045000196245.00.88 - 1.391.1Out
Call
VKTX250516C0004250064942.50.0 - 2.741.49Out
Call
VKTX250516C00040000325840.01.34 - 1.671.41Out
Call
VKTX250516C0003750059137.51.67 - 2.541.62Out
Call
VKTX250516C00035000415235.02.09 - 2.42.05Out
Call
VKTX250516C00032500112532.52.49 - 2.972.75Out
Call
VKTX250516C00030000161330.03.55 - 3.83.35Out
Call
VKTX250516C0002750042627.54.6 - 4.94.5In
Call
VKTX250516C0002500027825.06.0 - 6.255.8In
Call
VKTX250516C000225001122.57.7 - 8.357.25In
Call
VKTX250516C000200005620.09.65 - 9.910.2In
Call
VKTX250516C000175001017.510.75 - 12.5514.0In
 Put
VKTX250516P00015000215.00.0 - 2.270.25Out
 Put
VKTX250516P000175004017.50.0 - 0.490.51Out
 Put
VKTX250516P0002000071420.00.6 - 1.090.71Out
 Put
VKTX250516P0002250017522.51.17 - 1.371.17Out
 Put
VKTX250516P00025000126225.02.0 - 2.162.16Out
 Put
VKTX250516P0002750082227.53.1 - 3.253.25Out
 Put
VKTX250516P00030000324230.04.35 - 4.74.75In
 Put
VKTX250516P0003250049532.55.65 - 6.355.5In
 Put
VKTX250516P00035000135435.07.9 - 8.358.28In
 Put
VKTX250516P0003750024737.510.0 - 10.359.82In
 Put
VKTX250516P00040000174140.012.1 - 12.5511.65In
 Put
VKTX250516P0004250078942.514.3 - 15.2514.82In
 Put
VKTX250516P0004500072945.016.6 - 17.3517.37In
 Put
VKTX250516P0004750024347.518.9 - 19.4519.92In
 Put
VKTX250516P0005000062750.021.3 - 21.921.35In
 Put
VKTX250516P0005250016352.523.55 - 24.1524.14In
 Put
VKTX250516P0005500028455.025.85 - 27.6528.73In
 Put
VKTX250516P0005750029557.528.45 - 30.4532.38In
 Put
VKTX250516P0006000027160.030.65 - 33.431.81In
 Put
VKTX250516P0006250014762.532.95 - 35.734.7In
 Put
VKTX250516P0006500010865.034.2 - 38.535.38In
 Put
VKTX250516P0006750021467.536.65 - 40.734.35In
 Put
VKTX250516P000700004270.039.15 - 43.240.5In
 Put
VKTX250516P000725001072.541.7 - 45.947.6In
 Put
VKTX250516P000750007675.044.15 - 48.245.9In
 Put
VKTX250516P00077500177.546.7 - 50.730.55In
 Put
VKTX250516P00080000480.049.15 - 53.1549.52In
 Put
VKTX250516P00082500082.551.65 - 56.051.65In
 Put
VKTX250516P00085000085.054.1 - 58.246.22In
 Put
VKTX250516P00090000090.059.2 - 63.251.2In
 Put
VKTX250516P00095000095.064.1 - 68.1564.1In
 Put
VKTX250516P001000000100.069.1 - 73.1550.0In
 Put
VKTX250516P001050000105.074.15 - 78.271.4In
 Put
VKTX250516P001100000110.079.1 - 83.179.1In
 Put
VKTX250516P001150000115.084.25 - 88.284.25In
 Put
VKTX250516P001200000120.089.1 - 93.289.1In

Viking Therapeutics Market Cap Over Time

   Market Cap   
       Timeline  

Viking Total Stockholder Equity

Total Stockholder Equity

924.29 Million

At this time, Viking Therapeutics' Total Stockholder Equity is fairly stable compared to the past year.

Viking Therapeutics Corporate Management

CPA CPAChief OfficerProfile
Michael MorneauVice AdministrationProfile
Marianne ManciniChief OfficerProfile
Geoffrey BarkerSenior DevelopmentProfile

Additional Tools for Viking Stock Analysis

When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.